» Articles » PMID: 10078776

Clarithromycin: Pharmacokinetic and Pharmacodynamic Interrelationships and Dosage Regimen

Overview
Journal J Chemother
Date 1999 Mar 17
PMID 10078776
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In the last decade three important pharmacodynamic parameters: T>MIC, Cmax/MIC and AUC/MIC, have been shown to correlate well with in-vitro antimicrobial efficacy and that found in animal models, differentiating among groups of antibiotics with diverse mechanisms of action such as exposure time or concentration-dependent effect. The macrolide antimicrobial agents display variable concentration-dependent killing, indicating the increasing importance of the Cmax parameter. Clarithromycin, whose T>MIC and AUC influence its clinical efficacy, is in an intermediate position between its progenitor, erythromycin, and the azalides. This paper reviews pharmacokinetic and pharmacodynamic characteristics of clarithromycin, examining the potential impact of these properties on the dose and the optimal interval between administrations.

Citing Articles

Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model.

Muhi S, Buultjens A, Porter J, Marshall J, Doerflinger M, Pidot S PLoS Negl Trop Dis. 2024; 18(5):e0011979.

PMID: 38701090 PMC: 11095734. DOI: 10.1371/journal.pntd.0011979.


Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.

Zeitlinger M, Wagner C, Heinisch B Clin Pharmacokinet. 2008; 48(1):23-38.

PMID: 19071882 DOI: 10.2165/0003088-200948010-00002.


Pharmacokinetic/pharmacodynamic evaluation of antimicrobial treatments of orofacial odontogenic infections.

Isla A, Canut A, Gascon A, Labora A, Ardanza-Trevijano B, Solinis M Clin Pharmacokinet. 2005; 44(3):305-16.

PMID: 15762771 DOI: 10.2165/00003088-200544030-00006.


Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia.

Tessier P, Kim M, Zhou W, Xuan D, Li C, Ye M Antimicrob Agents Chemother. 2002; 46(5):1425-34.

PMID: 11959578 PMC: 127127. DOI: 10.1128/AAC.46.5.1425-1434.2002.


Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Singh J, Burr B, Stringham D, Arrieta A Paediatr Drugs. 2001; 3(10):733-61.

PMID: 11706924 DOI: 10.2165/00128072-200103100-00003.